Dyslipidemia, the condition of elevated serum triglycerides, elevated low-density lipoprotein
cholesterol, and/or low high-density lipoprotein cholesterol, is a public health problem of
growing concern. Dyslipidemia clusters with other disorders of the metabolic syndrome that
together influence, and may derive from, chronic inflammation. While best recognized as a
risk factor for atherosclerotic cardiovascular disease, lipid dysregulation has recently been
shown to influence a variety of disease processes in several organ systems. This review …